MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Zimmer Biomet Holdings DSO Ratio 2011-2026 | ZBH
Annual DSO Ratio Zimmer Biomet Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69.5 | 69.7 | 69.5 | 72.5 | 83.9 | 62.4 | 58.7 | 69.7 | 76.2 | 88 | 71.2 | 73.9 | 72.2 | 68.8 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 88 | 58.7 | 71.9 |
Quarterly DSO Ratio Zimmer Biomet Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 73.2 | 69.1 | 72 | 72.5 | 67.3 | 67.3 | 70.5 | 67.1 | 68.8 | - | 34.9 | 32.1 | 69 | - | 76.1 | 60.3 | 72.3 | 59.8 | 68.7 | 108 | 72 | 58.5 | 65.8 | 62.6 | 61 | 56.2 | 63.4 | 58 | 63.8 | 68.1 | 77.7 | 72.3 | 72.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 108 | 32.1 | 66.5 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Bio-Rad Laboratories
BIO
|
66.9 | $ 291.61 | -1.51 % | $ 8.23 B |  USA |
 |
Align Technology
ALGN
|
86.7 | $ 186.6 | 0.04 % | $ 14 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
59.5 | - | 1.37 % | $ 20.5 M | USA |
 |
Bruker Corporation
BRKR
|
57.3 | $ 38.87 | -1.55 % | $ 5.79 K | USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
746 | - | -26.83 % | $ 2.62 M | USA |
 |
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | USA |
 |
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | USA |
 |
AdaptHealth Corp.
AHCO
|
43.8 | $ 12.32 | -2.65 % | $ 1.66 B | USA |
 |
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | USA |
 |
Cytosorbents Corporation
CTSO
|
73.2 | $ 0.6 | 1.51 % | $ 37.3 M | USA |
 |
EDAP TMS S.A.
EDAP
|
91.8 | $ 3.57 | 1.42 % | $ 134 M |  France |
 |
Boston Scientific Corporation
BSX
|
65.7 | $ 64.33 | -0.42 % | $ 95.2 B | USA |
 |
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | USA |
 |
Eargo
EAR
|
70.8 | - | - | $ 10.2 M | USA |
 |
ClearPoint Neuro
CLPT
|
55.6 | $ 10.53 | 0.67 % | $ 298 M | USA |
 |
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
137 | $ 25.88 | 0.66 % | $ 219 M | USA |
 |
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | USA |
 |
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
61.2 | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
120 | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
74.3 | $ 17.44 | -2.3 % | $ 409 M | USA |
 |
Globus Medical
GMED
|
76.8 | $ 93.35 | -1.25 % | $ 12.6 B | USA |
 |
Helius Medical Technologies
HSDT
|
53.3 | $ 1.93 | -0.52 % | $ 1.17 M | USA |
 |
Butterfly Network
BFLY
|
76.1 | $ 5.07 | 4.11 % | $ 1.07 B | USA |
 |
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | USA |
 |
LENSAR
LNSR
|
38.9 | $ 6.01 | -3.84 % | $ 71.9 M | USA |
 |
Inogen
INGN
|
35.8 | $ 6.17 | -0.48 % | $ 164 M | USA |
 |
IRIDEX Corporation
IRIX
|
47.5 | $ 1.03 | -0.96 % | $ 17.4 M | USA |
 |
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
48.5 | $ 10.8 | -1.73 % | $ 387 M | USA |
 |
Inspire Medical Systems
INSP
|
42.6 | $ 56.58 | -0.14 % | $ 1.66 B | USA |
 |
CONMED Corporation
CNMD
|
64.5 | $ 38.82 | -1.62 % | $ 1.2 B | USA |
 |
LivaNova PLC
LIVN
|
53.8 | $ 64.92 | -0.34 % | $ 3.54 B |  Britain |
 |
Integer Holdings Corporation
ITGR
|
58.2 | $ 88.34 | 0.6 % | $ 3.07 B | USA |
 |
FONAR Corporation
FONR
|
237 | $ 18.8 | 0.16 % | $ 123 M | USA |
 |
Invacare Corporation
IVC
|
206 | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
38.2 | $ 78.68 | 0.63 % | $ 46 B | USA |
 |
Penumbra
PEN
|
46.5 | $ 332.47 | 0.02 % | $ 12.9 B | USA |